575 abstracts found.
Results filter
- Year: 2016 Remove Filter
F-18 labelled 3’-deoxy-3’-fluorothymidine (FLT) positron emission tomography (PET) imaging in patients with advanced pancreatic ductal adenocarcinoma: proof-of-concept reproducibility sub-analysis.
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom,2Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom,3University of Manchester Wolfson Molecular Imaging Centre (WMIC), Institute of Population Health, Manchester, United Kingdom,4Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, United Kingdom,5Department of Medical Oncology, The Christie NHS Foundation Trust; Institute of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom,6Department of Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom,7Department of Applications, Imanova Centre for Imaging Sciences, London, United Kingdom
THE PROMIS STUDY: DIAGNOSTIC ACCURACY OF MRI AND TRUS BIOPSY IN PROSTATE CANCER
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1MRC Clinical Trials Unit at UCL,2University College London,3University of York,4Hampshire Hospitals NHS Foundation Trust,5University College London Hospital NHS Foundation Trust,6Patient and Public Representative,7Royal Marsden Hospital,8PROMIS Collaborators
Comprehensive analysis of cell-free tumour DNA in plasma and urine tracks disease burden and reveals clonal evolution in muscle invasive bladder cancer
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1University of Cambridge,2Netherlands Cancer Institute,3University College London
Molecular Profiling of Circulating Tumour Cells (CTCs) in Non-small cell lung cancer within the TRACERx study of Intratumoural Heterogeneity and Evolution
Year: 2016
Session type: Oral
Theme: Cancer cells and model systems
1Postdoctoral Scientist,2Cancer Research UK Manchester Institute,3The Francis Crick Institute,London, UK,4The Francis Crick Institute,London, UK and and on behalf of TRACERx consortium and Cancer Research UK Manchester/UCL Lung Cancer Centre of Excellence,5Cancer Research UK Manchester Institute and on behalf of TRACERx consortium and Cancer Research UK Manchester/UCL Lung Cancer Centre of Excellence
Inhibiting HOX-PBX binding in paediatric glioblastoma as a novel therapeutic treatment
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1University of Surrey,2University of Bradford
HPV drives tumor development throughout the head and neck: Improved prognosis is associated with an immune response largely restricted to the oropharynx
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1University College London,2University of Southampton,3MD Anderson Cancer Center, University of Texas
Cell fate imbalance in the Oesophageal Epithelium: mutant cell competition
Year: 2016
Session type: Oral
Theme: Cancer cells and model systems
1Wellcome Trust-MRC Cambridge Stem Cell Institute
Targeting flap endonuclease 1 (FEN1) for personalization of ovarian cancer therapy
Year: 2016
Session type: Oral
Theme: Cancer cells and model systems
1Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK,2NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, USA,3Laboratory of Molecular Gerontology, Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224-6825, USA
Metformin increases 18F-FDG flux and inhibits fatty acid oxidation at clinical doses in breast cancer: results of a phase 0 clinical trial
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1University of Oxford,2University of Cambridge,3University of Liverpool,4Babraham Institute,5Oxford University Hospitals NHS Foundation Trust,6MD Andersen Cancer Centre,7McGill University
PARP trapping enhances oncolytic Reovirus cell killing in melanoma
Year: 2016
Session type: Oral
Theme: Diagnosis and therapy
1Instiitute of Cancer Research,2Institute of Cancer Research,3Institute of cancer research